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Introduction
Renal denervation (RDN) has been investigated as a new catheter-based treatment for resistant hypertension (Krum et al. 2009 (Krum et al. , 2014 . Renal denervation is used to treat other conditions, such as ventricular arrhythmia (VA) and heart failure (HF), and the modulation of cardiorenal interplay, which affects water and sodium retention and the autonomic neural regulation, has been hypothesized to be beneficial (Bohm et al. 2014; Bhave, 2017; Zhong et al. 2017) .
The kidneys have a dense afferent sensory and efferent sympathetic innervation and are positioned to be the origin as well as the target of sympathetic nervous system (SNS) activation (Booth et al. 2015a; Kopp 2015) . Afferent renal nerve (ARN) signals are centrally integrated into the CNS, primarily in the paraventricular nucleus (PVN), which mediates sympathetic nerve activity (SNA) and influences the cardiovascular system (Xu et al. 2015) . Enhanced afferent renal input to the PVN may result in a general increase in sympathetic tone during HF (Zheng & Patel, 2017) . Patel et al. (2016) recently showed that RDN may restore the decreased endogenous neuronal nitric oxide synthase (nNOS) in the PVN of rats, thereby contributing to the reduction in sympathetic tone during an established HF condition. Furthermore, HF is characterized by increased efferent renal sympathetic nerve activity (ERSNA) and impaired inhibitory reno-renal reflexes (IRRRs; Schiller et al. 2015) . Increased activation of ERSNA may lead to renal vasoconstriction and exaggerated activation of the renin-angiotensin-aldosterone system, contributing to elevated circulating angiotensin (Ang) II in HF (Booth et al. 2015a) . There is also evidence suggesting that when the IRRRs are blunted, excitatory reflexes may prevail and then contribute to increasing ERSNA (Kopp, 2015) . Additionally, Kopp et al. (2003) showed that the IRRRs can be suppressed by high circulating Ang II. It has also been shown previously that Ang II causes increased activation of SNS outflow via the PVN in HF (Zheng et al. 2009 ). Taken together, increased SNA to the kidney has the potential to increase ARN activation and circulating Ang II concentrations and to suppress IRRRs, which in turn provide feedback acting centrally to increase SNS activity inappropriately during HF (Zucker et al. 2012; Kopp, 2015; Barrett, 2015) .
Elevated RSNA and cardiac sympathetic nerve activity in HF may mediate reduced left ventricular (LV) contractile function and generate arrhythmias and, possibly, fibrillation (Simoes et al. 2004; Sasano et al. 2008) . Studies in experimental models of HF indicate that both surgical and catheter-based RDN may help to restore renal sodium and water equilibrium and attenuate cardiac remodelling (Zhao et al. 2013; Guo et al. 2014; Hu et al. 2014a; Li et al. 2015) . Recent animal experiments and clinical reports have also suggested that RDN can successfully improve ventricular electrical instability, indicating that elevated RSNA or altered renal afferent activity can contribute to the generation of arrhythmias (Ukena et al. 2012; Hoffmann et al. 2013; Linz et al. 2013; Huang et al. 2014; Remo et al. 2014) . Hence, modulation of RSNA and renal afferents by RDN might have beneficial effects on cardiac function and an antiarrhythmic effect in HF, but the potential electrophysiological mechanisms by which renal nerve manipulations affect arrhythmogenesis have not been completely elucidated to date. Therefore, the purpose of the present study was to investigate the effects of RDN on the vulnerability to ventricular fibrillation (VF) and the ventricular electrical properties in a rapid pacing-induced HF canine model.
Methods

Ethical approval
All animals were purchased from Shanghai Jiao Tong University Agriculture College (China) and raised in controlled conditions at the Department of Animals for Scientific Research, Shanghai Jiao Tong University School of Medicine. All procedures in this study were approved by Shanghai Jiao Tong University School of Medicine Animal Care and Use Committee (protocol registry no. A-2015-014) in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the US National Institutes of Health (8th edition, 2011). All experiments comply with the principles and regulations, as described in the editorial by Grundy (2015) . One animal per cage was housed in a temperature-regulated room (22-25°C), at 30-40% relative humidity, with a 12 h-12 h light-dark cycle and unlimited access to water and food. The experimental procedures were begun after the institutional veterinarian and animal care staff examined the animals and confirmed that the animals were in good health.
Animal preparation
In the present experiment, 18 beagles (weighing 13.0 ± 1.6 kg) were divided into the following three groups: control (n = 6), HF (n = 6) and HF+RDN (n = 6). The animals were injected I.M. with ketamine (10 mg kg −1 , Nhwa group Co., Ltd., Jiangsu, China) and atropine (0.04 mg kg −1 , Nhwa group Co., Ltd., Jiangsu, China) to induce general anaesthesia. After endotracheal tube placement, anaesthesia was maintained with propofol (1-2 mg kg −1 min −1 I.V., Humanwell Healthcare Co., Ltd., Hubei, China) and inhaled isoflurane (1-3%, Humanwell Healthcare Co., Ltd., Hubei, China), and fentanyl (1-2 μg kg −1 I.V. intermittently repeated as needed, Humanwell Healthcare Co., Ltd., Hubei, China) was used to maintain analgesia. General anaesthesia was used for all the surgeries, including pacemaker implantation, RDN and electrophysiological studies. Every effort was made to minimize animal suffering throughout the experiment. Anaesthetic monitoring included heart rate, respiratory rate and peripheral O 2 saturation. Attention was paid to the degree of muscle tone and any resistance to the ventilator. The animals were ventilated in a dorsally recumbent position. Mechanical ventilation (Datex-ohmeda 7100; General Electric Inc., Milwaukee, CT, USA) provided a fraction of inspired oxygen of 0.5 and a tidal volume of 12 ml kg −1 . The breathing frequency was ß15 breaths min −1 , with an inspiratory to expiratory ratio of 1:2. A heparin (Hepalink Pharmacetical Co., Ltd., Shenzhen, China) bolus of 100 U kg −1 was administered I.V. Continuous ECG and arterial blood pressure (BP) monitoring were performed throughout the study. At the conclusion of the experiment, the animals were killed by I.V. administration of a lethal dose of sodium pentobarbital (150 mg kg −1 , Nhwa group Co., Ltd., Jiangsu, China) under general anaesthesia.
Renal angiogram and radiofrequency ablation
Renal angiograms were performed before ablation. To determine the ablation targets, we applied high-frequency electrical nerve stimulation (ENS; 20 Hz frequency, 2 ms duration and 20 mA output) for 60 s before ablation (Gal et al. 2015) . Radiofrequency energy was then applied to the sites showing BP elevation during ENS to achieve six ablation points per renal artery. Each application was delivered for 60 s at 6-8 W with a 4 mm irrigated electrode catheter (Biosense Webster Inc., Diamond Bar, CA, USA) placed sequentially from distal to proximal in the bilateral renal arteries. This ENS protocol was repeated after ablation was completed, and a lack of any significant increase in the systolic BP indicated acute procedural success. Renal angiograms were performed after ablation to determine whether any arterial stenosis or injury occurred.
Pacemaker implantation
For the dogs in the HF group, a pacemaker (Kappa 710; Medtronic, Inc., Minneapolis, MN, USA) was implanted in a subcutaneous pocket and attached to a ventricular pacing lead (5076; Medtronic, Inc., Minneapolis, MN, USA) in the right ventricular apex via the right internal jugular vein under fluoroscopic visualization. For the dogs in the HF+RDN group, bilateral renal artery ablation was performed simultaneously with pacemaker implantation. After the surgery, the dogs were given prophylactic antibiotics (cefradine, 12.5 mg kg −1 , I.M., Kinhoo Pharmaceutical Co., Ltd., Zhuhai, China) daily for 3 days and subsequently underwent rapid ventricular pacing at 230 beats min −1 for 4 weeks. Dogs were monitored daily. Vital signs, the pacemaker implantation wound and any noticeable behavioural changes, including the animal's appetite, activity and/or mental status, were recorded on the animal's log chart. Rapid pacing was maintained until the day before the electrophysiological mapping study.
Echocardiography
Transthoracic two-dimensional echocardiography was performed in all animals before pacemaker implantation and after rapid pacing for 4 weeks. The left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV) and left ventricular end-diastolic volume (LVEDV) were measured to assess LV systolic function. Dogs were trained to lie calmly on their side and were imaged in the left decubitus position while awake. Echocardiographic data were acquired and analysed by an investigator blinded to the treatment.
Electrophysiological study
Pacing protocol. The heart was exposed through a median sternotomy and supported in a pericardial sling. A 64-unipolar basket catheter was placed into the LV through the left internal carotid to perform global endocardial mapping of the LV. A catheter (model 80993, IBI; St. Jude Medical Inc., Saint Paul, MN, USA), with the negative electrode in the right ventricular apex and the positive electrode in the superior vena cava, was inserted for defibrillation. A detailed description of this technique was presented in our earlier report (Jin et al. 2013 ).
Measurement of ventricular effective refractory period (VERP).
The VERP was determined using an incremental S 1 S 2 pacing protocol (MicroPaceIII, EPS320 Cardiac Stimulator; Micropace EP, Inc., Santa Ana, CA, USA). Both S 1 and S 2 stimuli were delivered at twice the diastolic threshold. The S 1 S 1 interval was 300 ms (eight beats), and the initial S 1 S 2 interval was 250 ms. The S 1 S 2 coupling interval was progressively shortened in steps of 10 ms, starting from 250 ms, until the premature pulse was blocked. The S 1 S 2 interval was then increased by 20 ms to restore capture and was subsequently shortened in 2 ms Q. Luo and others decrements until S 2 was blocked. The longest S 1 S 2 interval failing to capture was defined as the VERP.
Restitution pacing protocol. The restitution relationship was determined during pacing. Previous studies have measured the restitution properties by pacing 12-50 beats with different cycle lengths to secure a stable measurement. We chose 30 beats in this study to ensure a stable measurement and to avoid severe ischaemia that may be caused by too many fast pacing beats (Koller et al. 1998; Mahajan et al. 2008) . The pacing stimuli were delivered at twice the diastolic threshold. Trains of 30 S 1 stimuli were repeated at the following intervals. The pacing interval was decreased in 10 ms increments from 300 ms to an interval that induced VF or lost 1:1 capture. To capture during the shorter pacing intervals, the S 1 S 1 interval was initially 300 ms and then decreased in 10 ms increments until the target interval was reached; thereafter, the S 1 S 1 interval was maintained at the target interval for 30 beats. Pacing can alter autonomic outflow and thereby impact the assessment. Blood pressure decreased during the rapid pacing, whereas sympathetic activity to the heart increased. In the present study, when the pacing cycle length was 300-200 ms, there were sufficient 30-60 s intervals after each pacing sequence to allow BP to return to baseline. Although the pacing cycle length was <200 ms, 5 min was provided after each pacing to allow BP to return to baseline.
Activation recovery interval measurements. The activation recovery interval (ARI) was determined as an estimate of the action potential duration and the refractory period (Dhein et al. 1993) . The activation time in the unipolar electrograms was defined as the steepest downslope of the QRS complex, and the recovery time was defined as the fastest upslope of the T wave. The ARI was defined as the interval between the activation time and the recovery time.
Restitution properties. An exponential function, i.e. ARI = a + b × e −DI/c , was used to fit a restitution curve for each mapping electrode recording (Banville & Gray, 2002; Watanabe & Koller, 2002) . The diastolic interval (DI) is the difference between the pacing cycle length and the final ARI of the final paced beat, and a, b and c are model constants that are fitted by a least-squares procedure that halts when the difference in the calculated ARI between the final two iterations converges to <10 −8 . Only the restitution curves with a square of the correlation coefficient (R 2 ) > 0.8 were included in the analysis. The restitution slopes were calculated as the first derivatives of the exponential function at each DI, and the maximal slope was identified within the range of the exponentially determined DI.
Spatial heterogeneity. The dispersion of the ARI was quantified using the coefficient of variation (the SD divided by the mean) from all unipolar electrodes to evaluate the spatial heterogeneity.
Induction of VF and determination of VF threshold (VFT).
Ventricular fibrillation was induced during the restitution protocol described above. If VF was not induced twice during the restitution protocol, VF was induced by a 30 Hz stimulus delivered through the same electrode in the basket electrode. The maximal pacing cycle length to induce VF was defined as the VFT, which was used to assess the inducibility of VF.
Ventricular fibrillation activation rate and cycle length.
The VF activation rate was estimated by performing a fast Fourier transform analysis of the 2 s window of the VF recordings after the onset of arrhythmia at each electrode. The frequency with the highest power between 2 and 20 Hz was considered the activation rate. The VF cycle length was defined as the reciprocal of the activation rate.
Determination of defibrillation threshold (DFT).
After 20 s of VF, a biphasic shock (6/4 ms) was delivered (Teletronic Pacing Systems, 4510 Implant Support Device; Teletronics Pty Limited, Homebush West, NSW, Australia). The leading-edge energy of the first shock was 10 J. Depending on the success or failure of the shock, the leading-edge energy was decreased or increased by 2 J. The transition from failure to success or from success to failure was recorded as the first data point. The up-down algorithm was continued until the third reversal of success to failure or failure to success was reached. The DFT was determined by averaging the four shock strengths that formed the three reversals (Huang et al. 2002) . At least 5 min elapsed after each VF episode to allow the BP and heart rate to return to normal.
Statistical analysis
The results are expressed as the means ± SD. The variables were tested for normality of distribution. One-way ANOVA followed by a Newman-Keuls post hoc analysis was performed to compare the means of all continuous variables among the three groups. Student's paired t test was performed to compare the results of the echocardiographic measurements during the post-study for both the HF and HF+RDN groups. The differences between the qualitative variables were analysed by performing a χ 2 test. For all analyses, P < 0.05 was considered statistically significant. SPSS 16.0 package (SPSS Inc., Chicago, IL, USA) was used for the data analysis. 
Results
Echocardiographic changes
The echocardiographic characteristics observed in this study are summarized in Table 1 . After 4 weeks, a substantial reduction in LVEF and an increase in LVEDV and LVESV were observed in both the HF and HF+RDN groups; however, the dogs in the HF+RDN group had significantly higher LVEF and lower LVEDD and LVESV than those in the HF group (Table 1) .
Electrical nerve stimulation-guided renal ablation and renal angiogram Figure 1 shows the BP responses upon ENS before and after RDN. High-frequency ENS was applied before and after ablation. Before RDN, the systolic BP was significantly increased by the electrical stimulation delivered from the catheter to the renal nerves (from baseline 132 ± 15 to 151 ± 12 mmHg, P < 0.01). However, after RDN, the systolic BP was not altered by ENS (from 128 ± 13 to 130 ± 15 mmHg, P > 0.05; Fig. 1 ). In addition, renal artery occlusion was excluded by renal angiograms (Fig. 2) .
Effects of RDN on VFT and inducibility of VF
In the control group, five dogs (5/6, 83%) had VF induced by continuous S 1 S 1 pacing, whereas all dogs in the other two groups (6/6, 100%) had VF induced during S 1 S 1 programmed pacing. However, we observed that the VF episodes could transform into ventricular tachycardia (VT) and then terminate spontaneously in the HF+RDN dogs (Fig. 3) . Compared with the control group, VF was induced much earlier in the HF group (P < 0.01) and the HF+RDN group (P < 0.05) during S 1 S 1 continuous pacing. In contrast, compared with the HF group, in the HF+RDN group, the RDN significantly increased the VFT and decreased the pacing cycle length inducing VF (P < 0.05; Table 2 ). 
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Effects of RDN on VERP, ARI and dispersion of refractoriness
Compared with the control group, the VERP was significantly prolonged by 28% in the HF dogs (P < 0.01) and by 14% (P < 0.05) in the HF+RDN dogs. Compared with the HF group, the VERP was significantly decreased by 11% in the HF+RDN dogs (P < 0.05; Table 2 ).
To estimate the dispersion of refractoriness, the ARI was measured from each recording electrode at a pacing cycle length of 300 ms. Compared with the control group, the ARI and its dispersion of refractoriness were increased by 16% (P < 0.05) and 100% (P < 0.01) in the HF group and by 10% (P < 0.05) and 50% (P < 0.01) in the HF+RDN group, respectively. Compared with Figure 2 . Bilateral renal artery angiograms before and after ablation A, angiogram was performed before ablation. B, the catheter was inserted into the main left renal artery distally. C, the catheter was withdrawn gradually to the segment of the left renal artery during the ablation procedure. D, the catheter was inserted into the distal part of the main right renal artery. E, the catheter was placed sequentially in the segment of the right renal artery during the ablation procedure. F, no evidence of significant spasm, thrombosis or stenosis was observed after ablation.
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the HF group, RDN significantly decreased the ARI and dispersion of refractoriness in the HF+RDN group by 7% (P < 0.05) and 25% (P < 0.01), respectively ( Table 2) .
Effects of RDN on ventricular restitution properties
Compared with the control group, the maximal slope of the restitution curves significantly increased by 34% (P < 0.01) in the HF group and by 15% (P < 0.05) in the HF+RDN group. Compared with the HF group, RDN significantly flattened the ARI restitution curves and decreased the maximal slope of the restitution curve by 15% in the HF+RDN group (P < 0.05; Table 2 and Fig. 4 ).
Effects of RDN on the VF activation rate and DFT
Compared with the control group, the VF activation rate was much slower in the HF (P < 0.01) and HF+RDN (P < 0.05) groups. The VF cycle length was markedly longer in the HF (P < 0.01) and HF+RDN (P < 0.05) groups than in the control group. Notably, compared with the HF group, RDN markedly increased the VF activation rate (P < 0.05) and decreased the VF cycle length (P < 0.05; Table 2 ). Compared with the control group, the DFT was greatly increased by 96% (P < 0.01) in the HF group and by 42% (P < 0.05) in the HF+RDN group. However, compared with the HF dogs, RDN significantly decreased the DFT by 27% (P < 0.05) in the HF+RDN dogs (Table 2) .
Discussion
The major findings of this study are as follows: (i) RDN somewhat attenuated the reduction in the LVEF and the dilatation of the failing hearts; (ii) compared with the HF group without treatment, RDN increased the VFT and decreased the DFT; (iii) compared with the HF group, RDN significantly decreased the VERP, ARI and its dispersion; and (iv) RDN flattened the ARI ventricular restitution curve and decreased the maximal slope of the curve. The findings of this study suggested that RDN exerted a potential antifibrillatory action on VF in the canine pacing-induced HF model.
Renal denervation attenuates ventricular structural remodelling
In this study, we found thatRDN somewhat attenuated the impairment of LV systolic function and the process of ventricular enlargement compared with HF hearts. Hu and colleagues assessed the effects of RDN on the development of post-myocardial infarction HF and on the cardiac autonomic nervous system in rats and demonstrated that RDN improved LV function by increased water and sodium excretion, decreased noradrenaline, plasma renin, Ang II and aldosterone concentrations, and modulated cardiac autonomic activity, presumably via the specific denervation of renal afferent nerves (Hu et al. 2012 (Hu et al. , 2014 Antoine et al. 2017) . In addition, another study reported that RDN not only preserved the LVEF but also inhibited the development of LV mechanical dyssynchrony as detected by speckle-tracking echocardiography during the progression of HF in dogs (Hu et al. 2014b) . Therefore, RDN in HF may affect changes in cardiac function via relieving mechanical strain in the ventricular myocardium by facilitating sodium excretion and attenuating the excessive activation of the renin-angiotensin-aldosterone 153 ± 6.0 182 ± 14 * * 169 ± 10 * † ARI dispersion (coefficient of variation) 0.04 ± 0.01 0.08 ± 0.02 * * 0.06 ± 0.01 * * † ARI restitution slope 1.1 ± 0.09 1.48 ± 0.2 * * 1.26 ± 0.11 * † VFT (ms) 106 ± 8 135 ± 10 * * 118 ± 7.5 * † DFT (J)
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15.3 ± 3.7 30 ± 6.3 * * 21.8 ± 4.7 * † VF activation rate (Hz) 11.7 ± 0.38 9.4 ± 0.16 * * 10.1 ± 0.25 * † VF cycle length (ms) 85.5 ± 9.4 105.8 ± 10.0 * * 99 ± 9.6 * † Abbreviations: ARI, activation recovery interval; DFT, defibrillation threshold; HF, heart failure; RDN, renal denervation; VERP, ventricular effective refractory period; VF, ventricular fibrillation; and VFT, ventricular fibrillation threshold. * P < 0.05 and * * P < 0.01 compared with the control group. † P < 0.05 compared with the HF group.
system (Booth et al. 2015a; Antoine et al. 2017) . Hence, our findings are consistent with these studies, suggesting that RDN is likely to have a protective effect on ventricular structural remodelling and somewhat attenuates HF progression. However, RDN could not completely prevent the progression of HF. Gradual renal reinnervation has been shown in both afferent and efferent renal nerves after RDN, with partial return at 4 weeks and a complete restoration at 9-12 weeks in rat models (Mulder et al. 2013; Booth et al. 2015b) . Nevertheless, studies in dogs showed only partial or no renal reinnervation 3-12 months after RDN and renal transplantation (Almgard et al. 1971 ; et al. 1972 ). There may be one explanation for the phenomenon. In addition to the hyper-activation of the renin-angiotensin-aldosterone system and SNS during HF, numerous other hormones and cytokines, including vasopressin and endothelin, play important roles in the complex pathophysiology of HF and cardiorenal syndrome (Antoine et al. 2017) . Therefore, RDN alone is unlikely to prevent the development of HF, particularly in a pacing model of HF.
Nomura
Mechanism underlying the RDN-induced amelioration of ventricular electrical remodelling
According to the restitution hypothesis and the nonuniform dispersion of refractoriness hypothesis, a greater dispersion of refractoriness and a steep restitution slope may lead to dynamic instability and cause conduction block and re-entry, promoting the initiation and maintenance of cardiac fibrillation (Han & Moe, 1964; Antzelevitch, 2007) . Our previous studies have shown that a reduction in the dispersion of refractoriness and a flattened restitution slope after treatment with antiarrhythmic drugs could prevent or terminate the occurrence of VF (Jin et al. 2008 (Jin et al. , 2012 . In the present study, we found that RDN significantly reduced the dispersion of refractoriness and flattened the restitution slope, therefore contributing to stabilization of ventricular electrophysiological properties, which was consistent with our previous findings (Jin et al. 2008 (Jin et al. , 2012 . We presumed that the ventricular electrophysiological changes induced by RDN in HF might result, in part, from the modulation of cardiac SNA. Some experiments have supported this hypothesis. Lubanda et al. (2015) reported that RDN significantly affected autonomic heart control in favour of decreased SNA tone. Linz et al. (2013) suggested that RDN reduced ischaemia-induced VF and premature ventricular contractions in pigs by inhibiting SNS activity, which is comparable to pharmacological β-blocker therapy. Most importantly, Pinkham et al. (2017) recently showed, for the first time, that a direct interaction exists between RSNA and cardiac SNA in HF and demonstrated that surgical RDN improves cardiac sympathetic innervation and cardiac function in the failing heart that might otherwise provide a substrate for adversely affecting LV function to drive arrhythmias. Moreover, stimulation of the stellate ganglia has been reported to shorten the ARI, increase noradrenaline content and dispersion of repolarization, and induce a predisposition to VF (Vaseghi et al. 2012; Yagishita et al. 2015) . Bilateral cardiac sympathetic denervation reduces the VT/VF inducibility and mitigates the effects of sympathetic activation on the dispersion of repolarization in infarcted hearts without causing a haemodynamic compromise (Irie et al. 2017) . These studies may provide mechanistic insight into the beneficial effects of the neural control of the heart in reducing arrhythmias in patients.
Alterations in the VFT and DFT in HF by RDN
The VFT has been shown to be a powerful predictor of altered arrhythmia vulnerability in relationship to the autonomic nervous system, which is a quantifiable and reproducible measure reflecting electrical stability (Ng et al. 2007) . In the present study, our results demonstrated a significant increase in the VFT after RDN compared with that in HF dogs without treatment. According to the two hypotheses mentioned above, we showed that bilateral RDN significantly reduced ARI dispersion and caused a downward shift in the ventricular restitution curve compared with that in the failing hearts. Therefore, reduced refractoriness dispersion and a flattened slope of the ventricular restitution curve were associated with increased VFT.
Moreover, our results suggested that the DFT in the HF+RDN dogs was much lower than that in the HF dogs. Several potential mechanisms might be responsible for the DFT, such as the upper limit of vulnerability, critical mass, virtual electrode polarization and VF organization, and our earlier studies have shown that the DFT varied during different stages as VF progressed (Jacob et al. 2010; Jin et al. 2013) . The VF organization hypothesis states that more organized fibrillation corresponds to propagation of fewer complex wavefronts in the myocardium, thus making it easier to defibrillate. A major finding of the present study, which was discussed in detail above, was that RDN led to a reduction in the refractoriness dispersion and flattened the ARI restitution curve, which indicated a more highly organized VF. Additionally, we observed that more organized VF was induced, which could then transform into stable VT and even terminate spontaneously in the HF+RDN dogs (Fig. 3) .
In addition, the VF activation rate was increased by RDN in the treated hearts compared with the failing hearts. According to our results, RDN could significantly reduce the VERP and ARI in the treated hearts compared with the untreated failing hearts, thus leading to the potential increase in the VF activation rate. Previous studies have suggested that the electrophysiological substrate for VF was altered largely by the reduced excitability in HF, which then dramatically altered the VF dynamics, decreased the activation frequency and increased the complexity of VF (Huang et al. 2001; Moreno et al. 2005) . Hence, the potential mechanism of RDN-induced increases in the VF activation rate was the improved excitability of the ventricular myocardium. Thus, the electrophysiological characteristics altered by RDN during VF might explain, in part, the lower DFT.
Clinical implications
Strong but limited clinical evidence suggests that modification of renal nerves might be an adjunctive strategy in the clinical management of VA and HF. Remo et al. (2014) provided evidence regarding the safety and effectiveness of RDN as an adjunctive therapy in the treatment of VT resistant to standard interventions. Ukena et al. 2012 Ukena et al. , (2016 suggested that RDN reduces VT and even electrical storms in patients with HF. According to our findings in the present study, particularly the reduction in the restitution slope and ventricular dispersion, the increase in the VFT and the decrease in the DFT, we provide some mechanistic insight into the electrophysiological role of RDN in the treatment of ventricular arrhythmias in the clinical setting. Elevations in both cardiac and renal sympathetic tone are associated with increased morbidity in patients with HF. Hence, RDN is unsurprisingly also considered a treatment for HF (Fukuta et al. 2017; Hopper et al. 2017) . However, the role of RDN as an adjunctive or even standalone therapy in HF patients with malignant arrhythmias requires further research and clinical investigation.
Limitations
First, as previous studies indicated (Chinushi et al. 2013; de Jong et al. 2016) , the removal of the BP response is a reliable indicator of successful RDN. The direct assessment of the functional sympathetic control of the heart, immunohistochemical analysis of the kidneys and determination of noradrenaline content provide convincing evidence. Thus, the present study lacks a direct assessment of RDN efficacy, which should be evaluated in further study. Second, sham denervation was not performed in the HF group. The findings of the SYMPLICITY HTN-3 trial suggest that a significant reduction in SBP in patients with resistant hypertension does not occur after renal artery denervation compared with sham control treatment (Bhatt et al. 2014) . Therefore, Q. Luo and others this is one of the limitations of the present study. Third, HF provoked by ischaemia is more realistic than rapid pacing. Further studies should be designed to investigate the effect of RDN on HF caused by ischaemia.
Conclusions
Renal denervation significantly attenuated the process of ventricular enlargement and somewhat improved LV systolic function. Moreover, RDN significantly stabilized ventricular electrophysiological properties, including a flattening of the restitution curve, reducing the ARI dispersion and, thus, lowering the DFT and increasing the VFT in HF. The findings of this study indicate that RDN has potential antifibrillating properties for the prevention of VF and could be an effective therapy for the management of HF.
